The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Neurophysiological predictors of long term response to AChE inhibitors in AD patients
Open accessAbstract
BACKGROUND: In vivo evaluation of cholinergic circuits of the human brain has recently been introduced using a transcranial magnetic stimulation (TMS) protocol based on coupling peripheral nerve stimulation with motor cortex TMS (short latency afferent inhibition, SAI). SAI is reduced in Alzheimer's disease (AD) and drugs enhancing cholinergic transmission increase SAI. METHODS: We evaluated whether SAI testing, together with SAI test-retest, after a single dose of the acetylcholinesterase (AChE) inhibitor rivastigmine, might be useful in predicting the response after 1 year treatment with rivastigmine in 16 AD patients. RESULTS: Fourteen AD patients had pathologically reduced SAI. SAI was increased after administration of a single oral dose of rivastigmine in AD patients with abnormal baseline SAI, but individual responses to rivastigmine varied widely, with SAI change ranging from an increase in inhibition of approximately 50% of test size to no change. Baseline SAI and the increase in SAI after a single dose of rivastigmine were correlated with response to long term treatment. A normal SAI in baseline conditions, or an abnormal SAI in baseline conditions that was not greatly increased by a single oral dose of rivastigmine, were invariably associated with poor response to long term treatment, while an abnormal SAI in baseline conditions in conjunction with a large increase in SAI after a single dose of rivastigmine was associated with good response to long term treatment in most of the patients. CONCLUSIONS: Evaluation of SAI may be useful for identifying AD patients likely to respond to treatment with AChE inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“The amount of change in SAI after a single dose of rivastigmine was also strongly correlated with changes in cognitive measure assessed by the neuropsychological tests after 1 year of treatment. Changes revealed by two tests of long term verbal memory (immediate and delayed recall of RAVLT) correlated with acute chang…”
ResultCENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348
Aarsland, D., Larsen, J. P., Reinvang, I., & Aasland, A. M. (1994) · Brain · doi:10.1093/brain/117.6.1377 · Cited by 56 · cited 1×
“We also found a correlation between the acute change in SAI produced by rivastigmine, and the change in phonological verbal fluency after 1 year of treatment. This finding is consistent with the results of a previous study that showed that cholinergic blockade in healthy subjects determines an impairment of verbal flu…”
Result
Cited by
Ziemann, U., Reis, J., Schwenkreis, P., Rosanova, M., Strafella, A., Badawy, R., & Müller-Dahlhaus, F. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.08.028 · Cited by 681
The clinical diagnostic utility of transcranial magnetic stimulation: Report of an IFCN committee
Chen, R., Cros, D., Curra, A., Di Lazzaro, V., Lefaucheur, J.-P., Magistris, M. R., Mills, K., Rösler, K. M., Triggs, W. J., Ugawa, Y., et al. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.10.014 · Cited by 612
Self-citationNeurobiological after-effects of non-invasive brain stimulation
Cirillo, G., Di Pino, G., Capone, F., Ranieri, F., Florio, L., Todisco, V., Tedeschi, G., Funke, K., & Di Lazzaro, V. (2017) · Brain Stimulation · doi:10.1016/j.brs.2016.11.009 · Cited by 446
Self-citationPaulus, W., Classen, J., Cohen, L. G., Large, C. H., Di Lazzaro, V., Nitsche, M., Pascual-Leone, A., Rosenow, F., Rothwell, J. C., & Ziemann, U. (2008) · Brain Stimulation · doi:10.1016/j.brs.2008.06.002 · Cited by 414
“The suppression of SAI by scopolamine suggests that SAI may be a useful probe to test the integrity of central cholinergic neural circuits which in turn is supported by an abnormal reduction of SAI in patients with Alzheimer’s disease and dementia with Lewy bodies.(111,112) In summary, SAI seems a promising parameter…”
BackgroundDi Lazzaro, V., Pilato, F., Dileone, M., Profice, P., Ranieri, F., Ricci, V., Bria, P., Tonali, P. A., & Ziemann, U. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.07.005 · Cited by 240
Self-citation
Metadata
- Authors
- Di Lazzaro, V
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2005-08-01
- Volume
- 76
- Issue
- 8
- Pages
- 1064-1069
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2114271415
- Cited by
- 201
- References
- 3
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.